Literature DB >> 12623875

Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling.

Claire E Sears1, Simon M Bryant, Euan A Ashley, Craig A Lygate, Stevan Rakovic, Helen L Wallis, Stefan Neubauer, Derek A Terrar, B Casadei.   

Abstract

A neuronal isoform of nitric oxide synthase (nNOS) has recently been located to the cardiac sarcoplasmic reticulum (SR). Subcellular localization of a constitutive NOS in the proximity of an activating source of Ca2+ suggests that cardiac nNOS-derived NO may regulate contraction by exerting a highly specific and localized action on ion channels/transporters involved in Ca2+ cycling. To test this hypothesis, we have investigated myocardial Ca2+ handling and contractility in nNOS knockout mice (nNOS-/-) and in control mice (C) after acute nNOS inhibition with 100 micromol/L L-VNIO. nNOS gene disruption or L-VNIO increased basal contraction both in left ventricular (LV) myocytes (steady-state cell shortening 10.3+/-0.6% in nNOS-/- versus 8.1+/-0.5% in C; P<0.05) and in vivo (LV ejection fraction 53.5+/-2.7 in nNOS-/- versus 44.9+/-1.5% in C; P<0.05). nNOS disruption increased ICa density (in pA/pF, at 0 mV, -11.4+/-0.5 in nNOS-/- versus -9.1+/-0.5 in C; P<0.05) and prolonged the slow time constant of inactivation of ICa by 38% (P<0.05), leading to an increased Ca2+ influx and a greater SR load in nNOS-/- myocytes (in pC/pF, 0.78+/-0.04 in nNOS-/- versus 0.64+/-0.03 in C; P<0.05). Consistent with these data, [Ca2+]i transient (indo-1) peak amplitude was greater in nNOS-/- myocytes (410/495 ratio 0.34+/-0.01 in nNOS-/- versus 0.31+/-0.01 in C; P<0.05). These findings have uncovered a novel mechanism by which intracellular Ca2+ is regulated in LV myocytes and indicate that nNOS is an important determinant of basal contractility in the mammalian myocardium. The full text of this article is available at http://www.circresaha.org.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623875     DOI: 10.1161/01.RES.0000064585.95749.6D

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  85 in total

1.  Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.

Authors:  Liliya M Yamaleyeva; Sarah H Lindsey; Jasmina Varagic; Li Li Zhang; Patricia E Gallagher; Alex F Chen; Mark C Chappell
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

2.  Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation.

Authors:  Honglan Wang; Serge Viatchenko-Karpinski; Junhui Sun; Inna Györke; Nancy A Benkusky; Mark J Kohr; Héctor H Valdivia; Elizabeth Murphy; Sandor Györke; Mark T Ziolo
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

3.  Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.

Authors:  Janet R Manning; Gregory Carpenter; Darius R Porter; Stacey L House; Daniel A Pietras; Thomas Doetschman; Jo el J Schultz
Journal:  Growth Factors       Date:  2012-02-06       Impact factor: 2.511

4.  Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Authors:  Nadiia Rozmaritsa; Torsten Christ; David R Van Wagoner; Hannelore Haase; Johannes-Peter Stasch; Klaus Matschke; Ursula Ravens
Journal:  Cardiovasc Res       Date:  2013-12-12       Impact factor: 10.787

Review 5.  NO/redox disequilibrium in the failing heart and cardiovascular system.

Authors:  Joshua M Hare; Jonathan S Stamler
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart.

Authors:  Kuan-Cheng Chang; Andreas S Barth; Tetsuo Sasano; Eddy Kizana; Yuji Kashiwakura; Yiqiang Zhang; D Brian Foster; Eduardo Marbán
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

Review 7.  Physiological implications of the interaction between the plasma membrane calcium pump and nNOS.

Authors:  Elizabeth J Cartwright; Delvac Oceandy; Ludwig Neyses
Journal:  Pflugers Arch       Date:  2008-01-29       Impact factor: 3.657

8.  Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling.

Authors:  Shakil A Khan; Kwangho Lee; Khalid M Minhas; Daniel R Gonzalez; Shubha V Y Raju; Ankit D Tejani; Dechun Li; Dan E Berkowitz; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

9.  A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.

Authors:  Matthijs L Becker; Loes E Visser; Christopher Newton-Cheh; Albert Hofman; André G Uitterlinden; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

10.  Partial restoration of cardiac function with ΔPDZ nNOS in aged mdx model of Duchenne cardiomyopathy.

Authors:  Yi Lai; Junling Zhao; Yongping Yue; Nalinda B Wasala; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2014-01-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.